SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-261296
Filing Date
2011-09-30
Accepted
2011-09-30 15:40:57
Documents
10
Period of Report
2011-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d221450d10q.htm 10-Q 253808
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A - 14 (A) d221450dex311.htm EX-31.1 9846
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A - 14 (A) d221450dex312.htm EX-31.2 9949
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTIONS 1350 d221450dex32.htm EX-32 5187
  Complete submission text file 0001193125-11-261296.txt   2145693

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT neog-20110831.xml EX-101.INS 211257
6 XBRL TAXONOMY EXTENSION SCHEMA neog-20110831.xsd EX-101.SCH 20557
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20110831_cal.xml EX-101.CAL 41220
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20110831_def.xml EX-101.DEF 36390
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20110831_lab.xml EX-101.LAB 211061
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20110831_pre.xml EX-101.PRE 145637
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 111116884
SIC: 2835 In Vitro & In Vivo Diagnostic Substances